Dennis M. Mcgrath

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael A. Gordon, by power of attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Dennis M. Mcgrath

Form 4 holding Director

CITIUS ONCOLOGY, INC.

Security class
Stock Option (Right to Buy)
Shares / value
150,000
Estimated value
$313,500
Report date
19 Sep 2025
Price
$2.09
Ownership
Direct
Underlying class
Common Stock
Underlying amount
150,000
Form 4 holding President and CFO

PAVmed Inc.

Security class
Common stock
Shares / value
186,695
Estimated value
$41,222
Report date
02 Apr 2026
Price
$0.2208
Ownership
Direct
Form 4 holding Director

Citius Pharmaceuticals, Inc.

Security class
Stock Option (Right to Purchase Common Stock)
Shares / value
125,000
Estimated value
Report date
07 Nov 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Dennis M. Mcgrath

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .